Human immunodeficiency virus infection and its association with sarcopenia

Brazilian Journal of Infectious Diseases

Volumn 20, Issue 1, 2016, Pages 99-102

  Pinto Neto, Lauro Ferreira da Silva ^a   Sales, Marina Cerqueira ^b   Scaramussa, Eduarda Sobral ^b   da Paz, Clara Junia Calazans ^b   Morelato, Renato Lirio ^a  

^a Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^b Hospital Santa Casa de Misericóridia de Vitória   (Brazil)

Author keywords

Frailty; HIV; Sarcopenia

Indexed keywords

ATAZANAVIR; EFAVIRENZ; LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYNAMOMETER; FEMALE; GERIATRIC PATIENT; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; INFECTION RISK; MALE; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SARCOPENIA; VIRUS LOAD; WALKING SPEED; BRAZIL; CASE CONTROL STUDY; COMPLICATION; HIV INFECTIONS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BRAZIL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SARCOPENIA; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84957435151     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2015.10.003     Document Type: Article

References (19)

1. Rosenberg I.H. Summary comments. Am J Clin Nutr 1989, 50:1231-1233.
2. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr 1997, 127(5 Suppl.):990S-991S.
3. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
4. Deeks S.G., Lewin S.R., Havlir D.V. The end of AIDS: HIV infection as a chronic disease. Lancet 2013, 382:1525-1533.
5. Solomon P., O'Brien K., Wilkins S., Gervais N. Aging with HIV: a model of disability. J Int Assoc Provid AIDS Care 2014, 13:519-525.
6. Young B., Dao C.N., Buchacz K., Baker R., Brooks J.T. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 2011, 52:1061-1068. HIV Outpatient Study (HOPS) Investigators.
7. Von Haehling S., Morley J.E., Anker S.D. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 2010, 1:129-133.
8. Morley J.E., Vellas B., Van Kan G.A., et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013, 14:392-397.
9. Janssen I., Heymsfield S.B., Baumgartner R.N., Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000, 89:465-471.
10. Janssen I., Baumgartner R.N., Ross R., Rosenberg I.H., Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004, 159:413-421.
11. Wasserman P., Segal-Maurer S., Rubin S.D. High prevalence of low skeletal muscle mass associated with male gender in midlife and older HIV-infected persons despite CD4 cell reconstitution and viral suppression. J Int Assoc Provid AIDS Care 2014, 13:145-152.
12. Alfonso J.C., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010, 39:412-423.
13. Yarasheski K.E., Scherzer R., Kotler D.P., et al. Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci 2011, 66:332-340.
14. Rees H.C., Meister E., Mohler M.J., Klotz S.A. HIV-related frailty is not characterized by sarcopenia. J Int Assoc Provid AIDS Care 2014, pii: 2325957414553848.
15. Önen N.F., Agbebi A., Shacham E., Stamm K.E., Onen A.R., Overton E.T. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 2009, 59:346-352.
16. Desquilbet L., Margolick J.B., Fried L.P., et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009, 50:299-306.
17. McComsey G.A., Tebas P., Shane E., et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010, 51:937-946.
18. Brown T.T., Hoy J., Borderi M., et al. Recommendations for evaluation and management of bone disease in HIV. Clin Inf Dis 2015, 60:1242-1251.
19. Erlandson K.M., Allshouse A.A., Jankowski C.M., MaWhinney S., Kohrt W.M., Campbell T.B. Functional impairment is associated with low bone and muscle mass among persons aging with HIV-infection. J Acquir Immune Defic Syndr 2013, 63:209-215.